| Synthesis and antitumor activity of optically active thiourea and their 2-aminobenzothiazole derivatives: A novel class of anticancer agents SN Manjula, NM Noolvi, KV Parihar, SAM Reddy, V Ramani, AK Gadad, ... European Journal of Medicinal Chemistry 44 (7), 2923-2929, 2009 | 192 | 2009 |
| A TLR4-interacting peptide inhibits lipopolysaccharide-stimulated inflammatory responses, migration and invasion of colon cancer SW480 cells M Rakhesh, M Cate, R Vijay, A Shrikant, A Shanjana Oncoimmunology 1 (9), 1495-1506, 2012 | 58 | 2012 |
| NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation JP Brosseau, CP Liao, Y Wang, V Ramani, T Vandergriff, M Lee, A Patel, ... Nature communications 9 (1), 5014, 2018 | 52 | 2018 |
| Blocking Monocytic Myeloid-Derived Suppressor Cell Function via Anti-DC-HIL/GPNMB Antibody Restores the In Vitro Integrity of T Cells from Cancer Patients M Kobayashi, JS Chung, M Beg, Y Arriaga, U Verma, K Courtney, ... Clinical Cancer Research 25 (2), 828-838, 2019 | 46 | 2019 |
| A TLR4-interacting SPA4 peptide inhibits LPS-induced lung inflammation V Ramani, R Madhusoodhanan, S Kosanke, S Awasthi Innate immunity 19 (6), 596-610, 2013 | 35 | 2013 |
| TLR4-interacting SPA4 peptide improves host defense and alleviates tissue injury in a mouse model of Pseudomonas aeruginosa lung infection S Awasthi, B Singh, V Ramani, J Xie, S Kosanke PLoS One 14 (1), e0210979, 2019 | 28 | 2019 |
| Bacillus anthracis lethal toxin reduces human alveolar epithelial barrier function M Langer, ES Duggan, JL Booth, VI Patel, RA Zander, R Silasi-Mansat, ... Infection and immunity 80 (12), 4374-4387, 2012 | 27 | 2012 |
| DC-HIL/Gpnmb is a negative regulator of tumor response to immune checkpoint inhibitors JS Chung, V Ramani, M Kobayashi, F Fattah, V Popat, S Zhang, ... Clinical Cancer Research 26 (6), 1449-1459, 2020 | 17 | 2020 |
| Toll-like receptor 4-interacting SPA4 peptide suppresses the NLRP3 inflammasome in response to LPS and ATP stimuli V Ramani, S Awasthi Journal of Leucocyte Biology 98 (6), 1037-1048, 2015 | 17 | 2015 |
| Melanoma-derived soluble DC-HIL/GPNMB promotes metastasis by excluding T-lymphocytes from the pre-metastatic niches V Ramani, T Teshima, K Tamura, JS Chung, M Kobayashi, PD Cruz Jr, ... Journal of Investigative Dermatology 138 (11), 2443-2451, 2018 | 16 | 2018 |
| Soluble DC-HIL/Gpnmb modulates T-lymphocyte extravasation to inflamed skin V Ramani, JS Chung, K Ariizumi, PD Cruz Jr Journal of Investigative Dermatology 142 (5), 1372-1380. e5, 2022 | 7 | 2022 |
| Mechanism of anti-inflammatory activity of TLR4-interacting SPA4 peptide S Awasthi, G Kumar, V Ramani, V Awasthi, KK Rodgers, J Xie, J Beierle, ... Immunohorizons 5 (8), 659-674, 2021 | 7 | 2021 |
| Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responses A Kumar, V Ramani, V Bharti, D de Lima Bellan, N Saleh, R Uzhachenko, ... Journal for ImmunoTherapy of Cancer 11 (5), 2023 | 2 | 2023 |
| Expression of soluble DC-HIL/gpnmb receptor in the blood of metastatic non-small cell lung carcinoma treated with anti-PD1/PDL1 monoclonal antibodies. JS Chung, V Ramani, M Kobayashi, V Popat, PD Cruz, DE Gerber, ... Journal of Clinical Oncology 37 (15_suppl), e14038-e14038, 2019 | 2 | 2019 |
| Toll-like receptor-4-interacting surfactant protein-A-derived peptide reduces inflammation in a mouse model of intratracheal lipopolysaccharide challenge. S Awasthi, G Kumar, J Xie, J Beierle, V Awasthi, V Ramani, B Singh, ... The Journal of Immunology 200 (1_Supplement), 174.10-174.10, 2018 | 1 | 2018 |
| Involvement of endoplasmic reticulum and histone proteins in immunomodulation by TLR4-interacting SPA4 peptide against Escherichia coli S Awasthi, B Singh, V Ramani, NM Godbole, C King Infection and Immunity 91 (12), e00311-23, 2023 | | 2023 |
| 701 Dysplastic nevi (DN) patients have high DC-HIL-expressing myeloid-derived suppressor cells (MDSC) that may confer increased risk for melanoma J Chung, V Ramani, P Cruz, S Savory, K Ariizumi Journal of Investigative Dermatology 140 (7), S94, 2020 | | 2020 |
| DC-HIL/Gpnmb checkpoint blockade as a synergistic combination for stereotactic ablative radiation (SAbR). V Ramani, JS Chung, M Kobayashi, J Schoenhals, PD Cruz, R Hannan, ... Journal of Clinical Oncology 37 (15_suppl), e14129-e14129, 2019 | | 2019 |
| 063 The DC-HIL/syndecan-4 (SD4) pathway regulates trafficking of effector T-lymphocytes from blood to skin V Ramani, J Chung, M Kobayashi, P Cruz, K Ariizumi Journal of Investigative Dermatology 139 (5), S11, 2019 | | 2019 |
| 824 DC-HIL expression determines response of metastatic B16 melanoma and LL2 lung carcinoma to anti-PDL1 treatment J Chung, V Ramani, M Kobayashi, P Cruz, K Ariizumi Journal of Investigative Dermatology 139 (5), S142, 2019 | | 2019 |
